Stephanie Chu Pannell

Stephanie Pannell practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Stephanie Pannell's NPI, 1407299225, was assigned on April 10, 2013. Stephanie Pannell graduated from David Geffen School of Medicine at UCLA in 2013. Stephanie Pannell holds California license A132591.

Stephanie Pannell's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Stephanie Pannell's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Stephanie Pannell is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Stephanie Pannell to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephanie Pannell practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Stephanie Pannell's primary specialty in the NPI Registry, under taxonomy code 208800000X. Stephanie Pannell is board certified in urology by the American Board of Urology. Stephanie Pannell is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, prostate inflammation or infection, prostate surgery and transurethral procedures among the conditions Stephanie Pannell treats.

CMS data shows 2,760 Medicare services from Stephanie Pannell across 15 procedure codes in 2024, for 385 Medicare patients. Medicare paid $98,426 for them. Every service was in an office.

CMS counts 385 Medicare patients who saw Stephanie Pannell in 2024. The largest group is 65 to 74, with 173 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Stephanie Pannell's median patient age at 65, with 31% women.

In 2024, Stephanie Pannell wrote 1,428 Medicare Part D claims for 349 patients. 87% of them were for generic drugs. CMS names the drug for 1,292 of them, across 22 drugs with 11 or more claims each, at $242,942 in total drug cost. In 2023, CMS named 978 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Stephanie Pannell for performance year 2024, reported as part of a group. Stephanie Pannell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Stephanie Pannell as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Stephanie Pannell in 2019. Stephanie Pannell's most frequent co-author is Cher X. Huang, MD.

CMS Open Payments shows 44 general payments to Stephanie Pannell from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $368.

Stephanie Pannell graduated from David Geffen School of Medicine at UCLA in 2013.

Stephanie Pannell is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.